Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10711 | 1040 | 46.8 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
373 | 3 | ENDOGENOUS RETROVIRUS//VIROLOGY//JOURNAL OF VIROLOGY | 32972 |
2228 | 2 | C MYB//B MYB//SRC | 4790 |
10711 | 1 | SRC//SRC INHIBITORS//SARACATINIB | 1040 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SRC | authKW | 536455 | 17% | 11% | 174 |
2 | SRC INHIBITORS | authKW | 470485 | 2% | 64% | 25 |
3 | SARACATINIB | authKW | 331195 | 2% | 59% | 19 |
4 | AZD0530 | authKW | 281845 | 1% | 80% | 12 |
5 | C SRC | authKW | 271913 | 6% | 14% | 65 |
6 | SRC KINASE INHIBITORS | authKW | 264228 | 1% | 75% | 12 |
7 | DASATINIB | authKW | 243572 | 7% | 11% | 73 |
8 | SRC KINASE | authKW | 161266 | 4% | 13% | 42 |
9 | SRC FAMILY KINASES | authKW | 152724 | 4% | 13% | 41 |
10 | SU6656 | authKW | 134207 | 1% | 57% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 8414 | 47% | 0% | 485 |
2 | Chemistry, Medicinal | 1744 | 13% | 0% | 132 |
3 | Cell Biology | 1599 | 21% | 0% | 222 |
4 | Biochemistry & Molecular Biology | 569 | 23% | 0% | 238 |
5 | Chemistry, Organic | 201 | 8% | 0% | 82 |
6 | Pharmacology & Pharmacy | 143 | 9% | 0% | 98 |
7 | Genetics & Heredity | 118 | 6% | 0% | 61 |
8 | Biophysics | 71 | 4% | 0% | 43 |
9 | Pathology | 32 | 2% | 0% | 24 |
10 | Medicine, Research & Experimental | 20 | 3% | 0% | 30 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHEM SCI ONCOL | 117437 | 0% | 100% | 4 |
2 | INFLAMMAT ASSOCIATED CARCINOGENESIS | 58719 | 0% | 100% | 2 |
3 | THER EUT AREA ARTHRIT BONE METAB | 58719 | 0% | 100% | 2 |
4 | ARTHRIT BONE METAB THER EUT AREA | 33026 | 0% | 38% | 3 |
5 | ABORAT INNOVAT CANC MED GYNECOL | 29359 | 0% | 100% | 1 |
6 | ANN ARBHOR S | 29359 | 0% | 100% | 1 |
7 | ASOCIAC ESPANOLA CANC AECC UNIT | 29359 | 0% | 100% | 1 |
8 | BAS PL BIOL | 29359 | 0% | 100% | 1 |
9 | BEASTON W SCOTLAND CANC CLIN | 29359 | 0% | 100% | 1 |
10 | BEHT ISRAEL DEACONESS MED | 29359 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR CANCER THERAPEUTICS | 5225 | 3% | 1% | 27 |
2 | CLINICAL CANCER RESEARCH | 3274 | 4% | 0% | 41 |
3 | ONCOGENE | 2548 | 4% | 0% | 40 |
4 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998 | 4% | 0% | 42 |
5 | INVESTIGATIONAL NEW DRUGS | 1636 | 1% | 0% | 12 |
6 | CANCER RESEARCH | 1330 | 4% | 0% | 43 |
7 | MOLECULAR CARCINOGENESIS | 1042 | 1% | 0% | 10 |
8 | ONCOTARGET | 833 | 2% | 0% | 19 |
9 | MOLECULAR CANCER RESEARCH | 758 | 1% | 0% | 7 |
10 | JOURNAL OF MEDICINAL CHEMISTRY | 686 | 2% | 0% | 23 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SRC | 536455 | 17% | 11% | 174 | Search SRC | Search SRC |
2 | SRC INHIBITORS | 470485 | 2% | 64% | 25 | Search SRC+INHIBITORS | Search SRC+INHIBITORS |
3 | SARACATINIB | 331195 | 2% | 59% | 19 | Search SARACATINIB | Search SARACATINIB |
4 | AZD0530 | 281845 | 1% | 80% | 12 | Search AZD0530 | Search AZD0530 |
5 | C SRC | 271913 | 6% | 14% | 65 | Search C+SRC | Search C+SRC |
6 | SRC KINASE INHIBITORS | 264228 | 1% | 75% | 12 | Search SRC+KINASE+INHIBITORS | Search SRC+KINASE+INHIBITORS |
7 | DASATINIB | 243572 | 7% | 11% | 73 | Search DASATINIB | Search DASATINIB |
8 | SRC KINASE | 161266 | 4% | 13% | 42 | Search SRC+KINASE | Search SRC+KINASE |
9 | SRC FAMILY KINASES | 152724 | 4% | 13% | 41 | Search SRC+FAMILY+KINASES | Search SRC+FAMILY+KINASES |
10 | SU6656 | 134207 | 1% | 57% | 8 | Search SU6656 | Search SU6656 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GARGALIONIS, AN , KARAMOUZIS, MV , PAPAVASSILIOU, AG , (2014) THE MOLECULAR RATIONALE OF SRC INHIBITION IN COLORECTAL CARCINOMAS.INTERNATIONAL JOURNAL OF CANCER. VOL. 134. ISSUE 9. P. 2019 -2029 | 65 | 71% | 8 |
2 | ALESHIN, A , FINN, RS , (2010) SRC: A CENTURY OF SCIENCE BROUGHT TO THE CLINIC.NEOPLASIA. VOL. 12. ISSUE 8. P. 599 -607 | 47 | 64% | 116 |
3 | JOHNSON, FM , GALLICK, GE , (2007) SRC FAMILY NONRECEPTOR TYROSINE KINASES AS MOLECULAR TARGETS FOR CANCER THERAPY.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 7. ISSUE 6. P. 651 -659 | 76 | 51% | 42 |
4 | SUMMY, JM , GALLICK, GE , (2003) SRC FAMILY KINASES IN TUMOR PROGRESSION AND METASTASIS.CANCER AND METASTASIS REVIEWS. VOL. 22. ISSUE 4. P. 337-358 | 67 | 41% | 508 |
5 | PULS, LN , EADENS, M , MESSERSMITH, W , (2011) CURRENT STATUS OF SRC INHIBITORS IN SOLID TUMOR MALIGNANCIES.ONCOLOGIST. VOL. 16. ISSUE 5. P. 566 -578 | 46 | 65% | 53 |
6 | CHATZIZACHARIAS, NA , KOURAKLIS, GP , GIAGINIS, CT , THEOCHARIS, SE , (2012) CLINICAL SIGNIFICANCE OF SRC EXPRESSION AND ACTIVITY IN HUMAN NEOPLASIA.HISTOLOGY AND HISTOPATHOLOGY. VOL. 27. ISSUE 6. P. 677 -692 | 64 | 50% | 10 |
7 | KARIM, SA , CREEDON, H , PATEL, H , CARRAGHER, NO , MORTON, JP , MULLER, WJ , EVANS, TRJ , GUSTERSON, B , SANSOM, OJ , BRUNTON, VG , (2013) DASATINIB INHIBITS MAMMARY TUMOUR DEVELOPMENT IN A GENETICALLY ENGINEERED MOUSE MODEL.JOURNAL OF PATHOLOGY. VOL. 230. ISSUE 4. P. 430-440 | 44 | 68% | 6 |
8 | SIEMANN, DW , DONG, MY , PAMPO, C , SHI, WY , (2012) SRC-SIGNALING INTERFERENCE IMPAIRS THE DISSEMINATION OF BLOOD-BORNE TUMOR CELLS.CELL AND TISSUE RESEARCH. VOL. 349. ISSUE 2. P. 541-550 | 42 | 72% | 0 |
9 | ELSBERGER, B , (2014) TRANSLATIONAL EVIDENCE ON THE ROLE OF SRC KINASE AND ACTIVATED SRC KINASE IN INVASIVE BREAST CANCER.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 89. ISSUE 3. P. 343-351 | 32 | 80% | 11 |
10 | LIEU, C , KOPETZ, S , (2010) THE SRC FAMILY OF PROTEIN TYROSINE KINASES: A NEW AND PROMISING TARGET FOR COLORECTAL CANCER THERAPY.CLINICAL COLORECTAL CANCER. VOL. 9. ISSUE 2. P. 89-94 | 41 | 68% | 21 |
Classes with closest relation at Level 1 |